FDA.reportPublic FDA data

Alprolix 1 UNT Injection

RxCUI
1666323
RxNorm name
Alprolix 1 UNT Injection
Display name
Alprolix 1 UNT Injection
Full name
Alprolix 1 UNT Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:52

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125444AlprolixCoagulation Factor IX (Recombinant), Fc Fusion Protein351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
2fb3fb92-379d-4683-80d6-b06c0a7dc063ALPROLIX 1 UNT Injection [PSN] · coagulation factor IX recombinant immunoglobulin G1 fusion protein 1 UNT Injection [Alprolix] [SBD] · Alprolix 1 UNT Injection [SY]312These highlights do not include all the information needed to use ALPROLIX ® safely and effectively. See full prescribing information for ALPROLIX. ALPROLIX ® [coagulation factor IX (recombinant), Fc fusion protein], lyophilized powder for solution for intravenous injection. Initial U.S. Approval: 201420240516